LH
Laboratory Corporation of America Holdings
198.40
+
0.05
0.03%
12 x 190.00
8 x 202.99
bid
ask
10 @ 04:00 PM
199.14+0.74 (0.37%)
Bearish
8
Bullish
10
sentiment
197.01
day range
200.16
182.07
52 week range
232.56
Prev Close198.35
Open197.08
Low197.01
High200.16
Volume913.48K
Avg. Volume781.30K
Market Cap16.73B
Inst. Own98.84%
Beta0.99
Short Ratio3.11
Div & Yield2.88 / 1.45
EPS4.62
P/E42.94
1yr Target242.20
50day MA212.37
200day MA213.14
CNQ.TO
Canadian Natural Resources Limited
106.52
04:00 PM
+
0.84
0.79%
G.TO
Augusta Gold Corp.
0.96
03:59 PM
-
0.07
6.80%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.25
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2533.05
05:59 AM
-
46.55
1.80%
600690.SS
Haier Smart Home Co., Ltd.
28.35
03:00 AM
-
0.08
0.28%
0700.HK
Tencent Holdings Limited
348.40
04:08 AM
+
9.00
2.65%
1101.TW
Taiwan Cement Corp.
31.80
01:30 AM
-
0.20
0.62%
20MICRONS.NS
20 Microns Limited
162.85
05:59 AM
+
5.90
3.76%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Profile
...
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-25 | 2024-03 | 3.46 | 3.68 | 0.22 | 6.36% |
2024-02-15 | 2023-12 | 3.29 | 3.3 | 0.01 | 0.30% |
2023-10-26 | 2023-09 | 3.37 | 3.38 | 0.01 | 0.30% |
2023-07-27 | 2023-06 | 3.47 | 3.42 | -0.05 | -1.44% |
2023-04-25 | 2023-03 | 3.99 | 3.82 | -0.17 | -4.26% |
2023-02-16 | 2022-12 | 4.06 | 4.14 | 0.08 | 1.97% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-20 | B of A Securities | Upgrade | Buy | Buy |
2023-09-17 | Baird | Upgrade | Outperform | Outperform |
2023-09-14 | Mizuho | Upgrade | Buy | Buy |
2023-09-14 | Truist Securities | Upgrade | Buy | Buy |
2023-09-05 | HSBC | Upgrade | Hold | |
2023-08-13 | Wells Fargo | Upgrade | Overweight | Overweight |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-31 | BAILEY MEGAN D | Officer | 436.00 | Conversion of Exercise of derivative security |
2024-03-26 | BERBERIAN LANCE V | Chief Technology Officer | 28.01K | Conversion of Exercise of derivative security |
2024-03-26 | CAVENEY BRIAN J | Officer | 27.88K | Conversion of Exercise of derivative security |
2024-03-26 | DIVINCENZO JONATHAN P | Officer | 5.46K | Conversion of Exercise of derivative security |
2024-04-14 | EISENBERG GLENN A | Chief Financial Officer | 40.56K | Conversion of Exercise of derivative security |
2024-03-26 | SCHECHTER ADAM H | Chief Executive Officer | 93.63K | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 12.70M | 3.07B | 14.34% |
2023-06-29 | Vanguard Group Inc | 10.33M | 2.49B | 11.65% |
2023-06-29 | State Street Corporation | 3.93M | 948.56M | 4.44% |
2023-06-29 | Wellington Management Group, LLP | 2.06M | 497.72M | 2.33% |
2023-06-29 | Geode Capital Management, LLC | 1.88M | 452.77M | 2.12% |
2023-06-29 | Lazard Asset Management LLC | 1.73M | 417.17M | 1.95% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.76M | 666.20M | 3.12% |
2023-07-30 | Blackrock Equity Dividend Fund | 2.32M | 496.98M | 2.62% |
2023-06-29 | Vanguard 500 Index Fund | 2.11M | 509.21M | 2.38% |
2023-06-29 | Vanguard Mid-Cap Index Fund | 2.05M | 495.60M | 2.32% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 1.49M | 317.86M | 1.68% |
2023-05-30 | Fidelity 500 Index Fund | 991.44K | 210.71M | 1.12% |
Dividend
...
Dividend | Date |
---|---|
0.72 | 2024-05-28 |
0.72 | 2024-05-24 |
0.72 | 2024-02-26 |
0.72 | 2023-11-07 |
0.72 | 2023-08-07 |
0.8381 | 2023-05-17 |
Split
...
Split | Date |
---|---|
2 : 1 | 2002-05-13 |
2 : 1 | 2001-06-12 |
0.1 : 1 | 2000-05-04 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Why Is Labcorp Stock Trading Lower On Thursday?- Benzinga
news.google.com • -
Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View
news.google.com • -
Should Value Investors Buy Labcorp (LH) Stock?
zacks.com • -
Is Labcorp (LH) Stock Undervalued Right Now?
zacks.com • -
Oncology Space Gains Momentum: 3 Stocks in Focus
zacks.com • -
Labcorp launches 3-part blood test for Alzheimer's
reuters.com • -
The 7 Most Undervalued Value Stocks to Buy Now: August 2023
investorplace.com • -
Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
seekingalpha.com • -
Why Shares of Labcorp Dropped Monday
fool.com • -
Laboratory Corporation: Predictability Of Cash Flows Less Visible
seekingalpha.com • -
3 No-Brainer Stocks to Buy in a Correction
fool.com • -
LabCorp (LH) Misses Q1 Earnings Estimates
zacks.com • -
7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value
investorplace.com • -
8 Defensive Plays as Healthcare Stocks Stumble
barrons.com • -
LabCorp reports 20% drop in COVID test sales in Q4
marketwatch.com • -
Laboratory Corporation: Plenty Of Growth Runway
seekingalpha.com • -
Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
seekingalpha.com • -
2 Health Care Stocks That Fit Graham's Lost Formula
gurufocus.com • -
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
businesswire.com • -
Analysts Totally Blow It On 12 Gutsy Stock Recommendations
investors.com •